Peptimmune is Pharmaceuticals in United States that focus on peptide-copolymer therapeutics business. Founded in 2002. They cover business area such as developer, peptide, CNS, autoimmune disorder, multiple sclerosis, deep vaccine, viral, bacterial, and parasitic infectious disease.
2002
( 24 years old in 2026 )
Peptide-copolymer Therapeutics
-
64 Sidney Street
Suite 380
Cambridge, MA 02139
United States
Private
developerpeptideCNSautoimmune disordermultiple sclerosisdeep vaccineviral, bacterial, and parasitic infectious disease
* We use standard office opening hours in near Peptimmune's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Peptimmune is Pharmaceuticals business from United States that founded in 2002 (24 years old in 2026), Peptimmune business is focusing on Peptide-copolymer Therapeutics.
Peptimmune headquarter office and corporate office address is located in 64 Sidney Street Suite 380 Cambridge, MA 02139 United States.
Peptimmune was founded in United States.
In 2026, Peptimmune is currently focus on peptide-copolymer therapeutics sector.
Above is snippet of Google Trends for "peptide-copolymer therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Peptimmune, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
